Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.580
+0.120 (8.22%)
At close: Aug 1, 2025, 4:00 PM
1.610
+0.030 (1.90%)
After-hours: Aug 1, 2025, 4:58 PM EDT
Pliant Therapeutics Employees
Pliant Therapeutics had 171 employees as of December 31, 2024. The number of employees increased by 13 or 8.23% compared to the previous year.
Employees
171
Change (1Y)
13
Growth (1Y)
8.23%
Revenue / Employee
n/a
Profits / Employee
-$1,283,713
Market Cap
96.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 171 | 13 | 8.23% |
Dec 31, 2023 | 158 | 34 | 27.42% |
Dec 31, 2022 | 124 | 33 | 36.26% |
Dec 31, 2021 | 91 | 13 | 16.67% |
Dec 31, 2020 | 78 | 16 | 25.81% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PLRX News
- 5 weeks ago - Pliant Therapeutics Provides Update on BEACON-IPF - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference - GlobeNewsWire
- 3 months ago - Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations - GlobeNewsWire
- 4 months ago - Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference - GlobeNewsWire
- 4 months ago - Pliant Therapeutics: An Activist On Deck - Seeking Alpha
- 4 months ago - Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - GlobeNewsWire
- 5 months ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - PRNewsWire